why choose us

First received: December 08, 2022

Clinical Trial: Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection

Study Status: Completed

Recruit Status: RECRUITING

Condition: SARS CoV-2 Post-Acute Sequelae

Study Type: INTERVENTIONAL


Official Title: PET Imaging of Neuroinflammation in Patients With Neurological Dysfunction After SARS-CoV-2 Infection

Brief Summary: This clinical imaging study will use the small molecule translocator protein (TSPO) ligand, Fluorodeoxyglucose(18F)-labeled DPA-714, to visualize and quantify neuroinflammation in individuals with post-acute sequelae of SARS-CoV-2 (PASC) .The brain uptake of DPA-714 will be contrasted with healthy subjects.

Read more